Cleared Traditional

K191785 - Orion LifeSpan MEG (FDA 510(k) Clearance)

Feb 2020
Decision
226d
Days
Class 2
Risk

K191785 is an FDA 510(k) clearance for the Orion LifeSpan MEG. This device is classified as a Magnetoencephalograph (Class II - Special Controls, product code OLY).

Submitted by Compumedics Limited (Abbotsford, AU). The FDA issued a Cleared decision on February 14, 2020, 226 days after receiving the submission on July 3, 2019.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Acquire, Display, Store, And Archive Biomagnetic Signals Produced By Electrically Active Nerve Tissue In The Brain To Provide Information About The Location Of Active Nerve Tissue Responsible For Certain Brain Functions Relative To Brain Anatomy..

Submission Details

510(k) Number K191785 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 03, 2019
Decision Date February 14, 2020
Days to Decision 226 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OLY - Magnetoencephalograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Biomagnetic Signals Produced By Electrically Active Nerve Tissue In The Brain To Provide Information About The Location Of Active Nerve Tissue Responsible For Certain Brain Functions Relative To Brain Anatomy.